Stay updated on TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.

Latest updates to the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3, indicating a new page revision.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded a new site revision tag (Revision: v3.4.2) and removed the older government funding notice; the core study details and page content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedNotable updates include a government funding notice at the top of the page and a new Nat Med citation for autologous multiantigen-targeted T cell therapy in pancreatic cancer, with the previous Nat Med citation removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedNon-significant updates include UI/metadata changes: the page now shows a glossary toggle, new Last Update fields (Submitted that Met QC Criteria and Last Update Posted), a No FEAR Act Data notice, and a Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.